The global nutraceutical CDMO market is on a trajectory of impressive growth, with a projected year-over-year increase of 6.8%. According to recent forecasts, the market, valued at USD 35,730.8 million in 2024, is set to surge to USD 61,655.3 million by 2034. This robust expansion is underpinned by a compound annual growth rate (CAGR) of 5.6% over the forecast period.